SHPS1_HUMAN - dbPTM
SHPS1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SHPS1_HUMAN
UniProt AC P78324
Protein Name Tyrosine-protein phosphatase non-receptor type substrate 1
Gene Name SIRPA
Organism Homo sapiens (Human).
Sequence Length 504
Subcellular Localization Membrane
Single-pass type I membrane protein.
Protein Description Immunoglobulin-like cell surface receptor for CD47. Acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. Supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. May play a key role in intracellular signaling during synaptogenesis and in synaptic function (By similarity). Involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin. Mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells..
Protein Sequence MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGSPDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLVALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
83UbiquitinationRELIYNQKEGHFPRV
CEEEEECCCCCCCCE
63.12-
98UbiquitinationTTVSDLTKRNNMDFS
EEHHHHHHHCCCEEE
61.50-
120PhosphorylationPADAGTYYCVKFRKG
CCCCCEEEEEEECCC
7.21-
136PhosphorylationPDDVEFKSGAGTELS
CCCCEEECCCCCEEE
38.9129978859
140PhosphorylationEFKSGAGTELSVRAK
EEECCCCCEEEEEEC
32.9729978859
143PhosphorylationSGAGTELSVRAKPSA
CCCCCEEEEEECCCC
11.8829978859
182 (in isoform 2)Ubiquitination-4.7621890473
182 (in isoform 1)Ubiquitination-4.7621890473
183UbiquitinationSPRDITLKWFKNGNE
CCCCEEEEEEECCCC
41.7721890473
183UbiquitinationSPRDITLKWFKNGNE
CCCCEEEEEEECCCC
41.7721890473
183UbiquitinationSPRDITLKWFKNGNE
CCCCEEEEEEECCCC
41.7721890473
183 (in isoform 2)Ubiquitination-41.77-
186UbiquitinationDITLKWFKNGNELSD
CEEEEEEECCCCCCC
63.9322817900
192PhosphorylationFKNGNELSDFQTNVD
EECCCCCCCCCCCCC
30.15-
198UbiquitinationLSDFQTNVDPVGESV
CCCCCCCCCCCCCCC
11.3323000965
204PhosphorylationNVDPVGESVSYSIHS
CCCCCCCCCEEEEEE
15.50-
245N-linked_GlycosylationDPLRGTANLSETIRV
CCCCCCCCHHCCEEC
43.8916335952
247O-linked_GlycosylationLRGTANLSETIRVPP
CCCCCCHHCCEECCC
32.2828657654
259PhosphorylationVPPTLEVTQQPVRAE
CCCCEEEECCCCCCC
16.4730257219
270N-linked_GlycosylationVRAENQVNVTCQVRK
CCCCCEEEEEEEEEE
17.3919159218
272O-linked_GlycosylationAENQVNVTCQVRKFY
CCCEEEEEEEEEECC
7.6328657654
272PhosphorylationAENQVNVTCQVRKFY
CCCEEEEEEEEEECC
7.6330257219
292N-linked_GlycosylationLTWLENGNVSRTETA
EEEEECCCCCEEEEE
39.9219159218
301PhosphorylationSRTETASTVTENKDG
CEEEEECEEEECCCC
29.0525307156
319N-linked_GlycosylationWMSWLLVNVSAHRDD
EEEEEEEEEECCCCC
23.23UniProtKB CARBOHYD
404PhosphorylationRQKKAQGSTSSTRLH
HHHHCCCCCCCCCCC
17.0326699800
405PhosphorylationQKKAQGSTSSTRLHE
HHHCCCCCCCCCCCC
33.2629514088
406PhosphorylationKKAQGSTSSTRLHEP
HHCCCCCCCCCCCCC
31.2625056879
407PhosphorylationKAQGSTSSTRLHEPE
HCCCCCCCCCCCCCC
20.0325849741
408PhosphorylationAQGSTSSTRLHEPEK
CCCCCCCCCCCCCCC
36.7026699800
415UbiquitinationTRLHEPEKNAREITQ
CCCCCCCCCHHHHCC
67.6223000965
424PhosphorylationAREITQDTNDITYAD
HHHHCCCCCCCCCEE
25.6028152594
428PhosphorylationTQDTNDITYADLNLP
CCCCCCCCCEECCCC
18.6028152594
429PhosphorylationQDTNDITYADLNLPK
CCCCCCCCEECCCCC
9.8420007894
435 (in isoform 1)Ubiquitination-42.1321890473
436UbiquitinationYADLNLPKGKKPAPQ
CEECCCCCCCCCCCC
83.182190698
453PhosphorylationEPNNHTEYASIQTSP
CCCCCCCEEECCCCC
13.5510842184
464PhosphorylationQTSPQPASEDTLTYA
CCCCCCCCCCCCCEE
42.5626356563
467PhosphorylationPQPASEDTLTYADLD
CCCCCCCCCCEEEEC
19.5626356563
469PhosphorylationPASEDTLTYADLDMV
CCCCCCCCEEEECEE
20.8226356563
470PhosphorylationASEDTLTYADLDMVH
CCCCCCCEEEECEEE
10.9625884760
483AcetylationVHLNRTPKQPAPKPE
EECCCCCCCCCCCCC
69.1923749302
492PhosphorylationPAPKPEPSFSEYASV
CCCCCCCCCHHCEEE
39.4828152594
494PhosphorylationPKPEPSFSEYASVQV
CCCCCCCHHCEEEEC
33.7528152594
494O-linked_GlycosylationPKPEPSFSEYASVQV
CCCCCCCHHCEEEEC
33.7528657654
496PhosphorylationPEPSFSEYASVQVPR
CCCCCHHCEEEECCC
11.7227273156
498PhosphorylationPSFSEYASVQVPRK-
CCCHHCEEEECCCC-
16.5127273156

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
429YPhosphorylationKinaseMATKP42679
GPS
429YPhosphorylationKinaseTYR-KINASES-Uniprot
453YPhosphorylationKinaseMATKP42679
GPS
453YPhosphorylationKinaseTYR-KINASES-Uniprot
470YPhosphorylationKinaseIGF1RP08069
PSP
470YPhosphorylationKinaseTYR-KINASES-Uniprot
496YPhosphorylationKinaseIGF1RP08069
PSP
-KUbiquitinationE3 ubiquitin ligaseFBXO2Q9UK22
PMID:24658274

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SHPS1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SHPS1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CCD57_HUMANCCDC57physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SHPS1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-270 AND ASN-292, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-245, AND MASSSPECTROMETRY.

TOP